HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug iptacopan aims to save lives in rare transplant complication
Disease control Not yet recruitingThis study tests a new oral drug, Iptacopan, for a serious condition called TA-TMA that can happen after a stem cell transplant. TA-TMA damages small blood vessels and can be life-threatening. The trial will include 30 people aged 12 and older who have not improved with initial t…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC
-
Prepping the body before transplant: new study tests exercise program to boost recovery
Disease control Not yet recruitingThis study tests whether a personalized program of exercise, education, and support before a stem cell transplant can improve strength, reduce frailty, and enhance quality of life in adults with blood cancer. About 68 participants will be randomly assigned to either the prehabili…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: NA • Sponsor: Hospital del Salvador • Aim: Disease control
Last updated Jun 01, 2026 18:05 UTC